Scholarlink

Background <p>Precision Medicine in oncology is a rapidly evolving field aiming to prevent and treat cancers based on detailed patient and tumor characteristics. To better develop research studies, healthcare services and policies, and access to Precision Medicine, integration of insight and experiences of cancer patients and family members is required.</p> Objectives <p>In this paper, we describe the patient and family priorities regarding Precision Medicine as identified by the Atlantic Cancer Consortium Patient Advisory Committee (ACC PAC).</p> Methods <p>The ACC PAC was formed in January 2024 and met virtually five times between January and May of 2024. It included a diverse set of 12 patients and family members of patients from across the Atlantic Canadian provinces, a coordinator, an oncologist/clinician-scientist, and a cancer scientist. During meetings, the committee focused on identifying patient and family priorities in Atlantic Canada. Three guests with lived experiences were invited to further diversify the committee’s discussions. Discussions were summarized by the coordinator and cancer scientist. Summaries were then reviewed by the ACC PAC members in September 2024.</p> Results <p>The ACC PAC identified priorities on two general themes: (1) preventing and addressing cancer’s effects on the whole person/family (for example, by accessible information and support programs), and (2) understanding and accessing Precision Medicine (for example, by research, education, and wider implementation). While the ACC PAC members were optimistic about the utility of Precision Oncology, they also made it clear that it was unlikely to be sufficient without a team-based, holistic and equitable approach to cancer care. Better quality healthcare, education, resources, and effort by all stakeholders were established as essential for effective cancer control and Precision Medicine.</p> Conclusions <p>A key responsibility falls on the shoulders of funders, organizations, policy-makers and governments in addressing cancer’s effects, improving public knowledge of cancer and Precision Medicine, and improving access to high-quality healthcare and precision medicines. Patient partners and committees such as the ACC PAC can inform and help every step of these efforts with their patient-centered insights and perspectives.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Cancer, precision medicine, and Atlantic Canada: A priority setting exercise by the Atlantic Cancer Consortium Patient Advisory Committee

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年3月24日

查看全文
  • Sevtap Savas,
  • Georgia Skardasi,
  • Aaron A. Curtis,
  • Beverly Pausche,
  • Jennifer Coish,
  • John King,
  • Cyndi Corbett,
  • Marcelo F. Martinez,
  • Judy Donovan Whitty,
  • Sharon Jennings,
  • Cara MacInnis,
  • Angela Hyde

摘要

Background

Precision Medicine in oncology is a rapidly evolving field aiming to prevent and treat cancers based on detailed patient and tumor characteristics. To better develop research studies, healthcare services and policies, and access to Precision Medicine, integration of insight and experiences of cancer patients and family members is required.

Objectives

In this paper, we describe the patient and family priorities regarding Precision Medicine as identified by the Atlantic Cancer Consortium Patient Advisory Committee (ACC PAC).

Methods

The ACC PAC was formed in January 2024 and met virtually five times between January and May of 2024. It included a diverse set of 12 patients and family members of patients from across the Atlantic Canadian provinces, a coordinator, an oncologist/clinician-scientist, and a cancer scientist. During meetings, the committee focused on identifying patient and family priorities in Atlantic Canada. Three guests with lived experiences were invited to further diversify the committee’s discussions. Discussions were summarized by the coordinator and cancer scientist. Summaries were then reviewed by the ACC PAC members in September 2024.

Results

The ACC PAC identified priorities on two general themes: (1) preventing and addressing cancer’s effects on the whole person/family (for example, by accessible information and support programs), and (2) understanding and accessing Precision Medicine (for example, by research, education, and wider implementation). While the ACC PAC members were optimistic about the utility of Precision Oncology, they also made it clear that it was unlikely to be sufficient without a team-based, holistic and equitable approach to cancer care. Better quality healthcare, education, resources, and effort by all stakeholders were established as essential for effective cancer control and Precision Medicine.

Conclusions

A key responsibility falls on the shoulders of funders, organizations, policy-makers and governments in addressing cancer’s effects, improving public knowledge of cancer and Precision Medicine, and improving access to high-quality healthcare and precision medicines. Patient partners and committees such as the ACC PAC can inform and help every step of these efforts with their patient-centered insights and perspectives.